On the other hand, other studies show that DPP-4 inhibitor has no effect on blood pressure in renovascular hypertensive rats [45], increases blood pressure in SHR [46] and diminish hypotensive effects of high-dose of ACE inhibitor in subjects with metabolic syndrome [47]. This evidence concerns the gene DPP4 and metabolic syndrome.